Selected research
Market Structure
Global Pharma Forecasting Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharma Forecasting Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharma Forecasting Software include IQVIA, JMP, SAS Institute, Oracle, Inpharmation, J+D Forecasting, ZS Associate, Cognizant and Kinaxis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharma Forecasting Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharma Forecasting Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharma Forecasting Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharma Forecasting Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharma Forecasting Software Segment by Company
IQVIA
JMP
SAS Institute
Oracle
Inpharmation
J+D Forecasting
ZS Associate
Cognizant
Kinaxis
Axtria
Symphony Health
Manthan
Model N
Sarjen
Koerber Pharma
WNS
SoftGroup
Nanjing Haiwei Pharmaceutical Technology
Pharma Forecasting Software Segment by Type
Stability Prediction
Formulation and Process Development
Other
Pharma Forecasting Software Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other
Pharma Forecasting Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Forecasting Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Forecasting Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Forecasting Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharma Forecasting Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Forecasting Software industry.
Chapter 3: Detailed analysis of Pharma Forecasting Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Forecasting Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stability Prediction
- Formulation and Process Development
- Other
Applications
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Other
Companies covered
- IQVIA
- JMP
- SAS Institute
- Oracle
- Inpharmation
- J+D Forecasting
- ZS Associate
- Cognizant
- Kinaxis
- Axtria
- Symphony Health
- Manthan
- Model N
- Sarjen
- Koerber Pharma
- WNS
- SoftGroup
- Nanjing Haiwei Pharmaceutical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharma Forecasting Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Stability Prediction
- 1.2.3 Formulation and Process Development
- 1.2.4 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharma Forecasting Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Contract Research Organizations (CROs)
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharma Forecasting Software Growth Trends by Region
- 1.5.1 Global Pharma Forecasting Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharma Forecasting Software Market Size by Region (2021-2026)
- 1.5.3 Pharma Forecasting Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharma Forecasting Software Market Dynamics
- 2.1 Pharma Forecasting Software Industry Trends
- 2.2 Pharma Forecasting Software Industry Drivers
- 2.3 Pharma Forecasting Software Industry Opportunities and Challenges
- 2.4 Pharma Forecasting Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharma Forecasting Software Revenue by Company (2021-2026)
- 3.2 Global Pharma Forecasting Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharma Forecasting Software Key Company Head office and Area Served
- 3.4 Global Pharma Forecasting Software Company, Product Type & Application
- 3.5 Global Pharma Forecasting Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharma Forecasting Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharma Forecasting Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharma Forecasting Software Tier 1, Tier 2, and Tier 3
4 Pharma Forecasting Software Market by Type
- 4.1 Global Pharma Forecasting Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharma Forecasting Software Market Size by Type (2021-2032)
- 4.3 Global Pharma Forecasting Software Market Size Share by Type (2021-2032)
5 Pharma Forecasting Software Market by Application
- 5.1 Global Pharma Forecasting Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharma Forecasting Software Market Size by Application (2021-2032)
- 5.3 Global Pharma Forecasting Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 IQVIA
- 6.1.1 IQVIA Company Information
- 6.1.2 IQVIA Business Overview
- 6.1.3 IQVIA Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 IQVIA Pharma Forecasting Software Product Portfolio
- 6.1.5 IQVIA Recent Developments
- 6.2 JMP
- 6.2.1 JMP Company Information
- 6.2.2 JMP Business Overview
- 6.2.3 JMP Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 JMP Pharma Forecasting Software Product Portfolio
- 6.2.5 JMP Recent Developments
- 6.3 SAS Institute
- 6.3.1 SAS Institute Company Information
- 6.3.2 SAS Institute Business Overview
- 6.3.3 SAS Institute Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 SAS Institute Pharma Forecasting Software Product Portfolio
- 6.3.5 SAS Institute Recent Developments
- 6.4 Oracle
- 6.4.1 Oracle Company Information
- 6.4.2 Oracle Business Overview
- 6.4.3 Oracle Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Oracle Pharma Forecasting Software Product Portfolio
- 6.4.5 Oracle Recent Developments
- 6.5 Inpharmation
- 6.5.1 Inpharmation Company Information
- 6.5.2 Inpharmation Business Overview
- 6.5.3 Inpharmation Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Inpharmation Pharma Forecasting Software Product Portfolio
- 6.5.5 Inpharmation Recent Developments
- 6.6 J+D Forecasting
- 6.6.1 J+D Forecasting Company Information
- 6.6.2 J+D Forecasting Business Overview
- 6.6.3 J+D Forecasting Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 J+D Forecasting Pharma Forecasting Software Product Portfolio
- 6.6.5 J+D Forecasting Recent Developments
- 6.7 ZS Associate
- 6.7.1 ZS Associate Company Information
- 6.7.2 ZS Associate Business Overview
- 6.7.3 ZS Associate Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ZS Associate Pharma Forecasting Software Product Portfolio
- 6.7.5 ZS Associate Recent Developments
- 6.8 Cognizant
- 6.8.1 Cognizant Company Information
- 6.8.2 Cognizant Business Overview
- 6.8.3 Cognizant Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cognizant Pharma Forecasting Software Product Portfolio
- 6.8.5 Cognizant Recent Developments
- 6.9 Kinaxis
- 6.9.1 Kinaxis Company Information
- 6.9.2 Kinaxis Business Overview
- 6.9.3 Kinaxis Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Kinaxis Pharma Forecasting Software Product Portfolio
- 6.9.5 Kinaxis Recent Developments
- 6.10 Axtria
- 6.10.1 Axtria Company Information
- 6.10.2 Axtria Business Overview
- 6.10.3 Axtria Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Axtria Pharma Forecasting Software Product Portfolio
- 6.10.5 Axtria Recent Developments
- 6.11 Symphony Health
- 6.11.1 Symphony Health Company Information
- 6.11.2 Symphony Health Business Overview
- 6.11.3 Symphony Health Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Symphony Health Pharma Forecasting Software Product Portfolio
- 6.11.5 Symphony Health Recent Developments
- 6.12 Manthan
- 6.12.1 Manthan Company Information
- 6.12.2 Manthan Business Overview
- 6.12.3 Manthan Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Manthan Pharma Forecasting Software Product Portfolio
- 6.12.5 Manthan Recent Developments
- 6.13 Model N
- 6.13.1 Model N Company Information
- 6.13.2 Model N Business Overview
- 6.13.3 Model N Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Model N Pharma Forecasting Software Product Portfolio
- 6.13.5 Model N Recent Developments
- 6.14 Sarjen
- 6.14.1 Sarjen Company Information
- 6.14.2 Sarjen Business Overview
- 6.14.3 Sarjen Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Sarjen Pharma Forecasting Software Product Portfolio
- 6.14.5 Sarjen Recent Developments
- 6.15 Koerber Pharma
- 6.15.1 Koerber Pharma Company Information
- 6.15.2 Koerber Pharma Business Overview
- 6.15.3 Koerber Pharma Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Koerber Pharma Pharma Forecasting Software Product Portfolio
- 6.15.5 Koerber Pharma Recent Developments
- 6.16 WNS
- 6.16.1 WNS Company Information
- 6.16.2 WNS Business Overview
- 6.16.3 WNS Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 WNS Pharma Forecasting Software Product Portfolio
- 6.16.5 WNS Recent Developments
- 6.17 SoftGroup
- 6.17.1 SoftGroup Company Information
- 6.17.2 SoftGroup Business Overview
- 6.17.3 SoftGroup Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 SoftGroup Pharma Forecasting Software Product Portfolio
- 6.17.5 SoftGroup Recent Developments
- 6.18 Nanjing Haiwei Pharmaceutical Technology
- 6.18.1 Nanjing Haiwei Pharmaceutical Technology Company Information
- 6.18.2 Nanjing Haiwei Pharmaceutical Technology Business Overview
- 6.18.3 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Product Portfolio
- 6.18.5 Nanjing Haiwei Pharmaceutical Technology Recent Developments
7 North America
- 7.1 North America Pharma Forecasting Software Market Size (2021-2032)
- 7.2 North America Pharma Forecasting Software Market Size by Type
- 7.2.1 North America Pharma Forecasting Software Market Size by Type (2021-2026)
- 7.2.2 North America Pharma Forecasting Software Market Size by Type (2027-2032)
- 7.2.3 North America Pharma Forecasting Software Market Share by Type (2021-2032)
- 7.3 North America Pharma Forecasting Software Market Size by Application
- 7.3.1 North America Pharma Forecasting Software Market Size by Application (2021-2026)
- 7.3.2 North America Pharma Forecasting Software Market Size by Application (2027-2032)
- 7.3.3 North America Pharma Forecasting Software Market Share by Application (2021-2032)
- 7.4 North America Pharma Forecasting Software Market Size by Country
- 7.4.1 North America Pharma Forecasting Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharma Forecasting Software Market Size by Country (2021-2026)
- 7.4.3 North America Pharma Forecasting Software Market Size by Country (2027-2032)
- 7.4.4 North America Pharma Forecasting Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharma Forecasting Software Market Size (2021-2032)
- 8.2 Europe Pharma Forecasting Software Market Size by Type
- 8.2.1 Europe Pharma Forecasting Software Market Size by Type (2021-2026)
- 8.2.2 Europe Pharma Forecasting Software Market Size by Type (2027-2032)
- 8.2.3 Europe Pharma Forecasting Software Market Share by Type (2021-2032)
- 8.3 Europe Pharma Forecasting Software Market Size by Application
- 8.3.1 Europe Pharma Forecasting Software Market Size by Application (2021-2026)
- 8.3.2 Europe Pharma Forecasting Software Market Size by Application (2027-2032)
- 8.3.3 Europe Pharma Forecasting Software Market Share by Application (2021-2032)
- 8.4 Europe Pharma Forecasting Software Market Size by Country
- 8.4.1 Europe Pharma Forecasting Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharma Forecasting Software Market Size by Country (2021-2026)
- 8.4.3 Europe Pharma Forecasting Software Market Size by Country (2027-2032)
- 8.4.4 Europe Pharma Forecasting Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharma Forecasting Software Market Size (2021-2032)
- 9.2 China Pharma Forecasting Software Market Size by Type
- 9.2.1 China Pharma Forecasting Software Market Size by Type (2021-2026)
- 9.2.2 China Pharma Forecasting Software Market Size by Type (2027-2032)
- 9.2.3 China Pharma Forecasting Software Market Share by Type (2021-2032)
- 9.3 China Pharma Forecasting Software Market Size by Application
- 9.3.1 China Pharma Forecasting Software Market Size by Application (2021-2026)
- 9.3.2 China Pharma Forecasting Software Market Size by Application (2027-2032)
- 9.3.3 China Pharma Forecasting Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharma Forecasting Software Market Size (2021-2032)
- 10.2 Asia Pharma Forecasting Software Market Size by Type
- 10.2.1 Asia Pharma Forecasting Software Market Size by Type (2021-2026)
- 10.2.2 Asia Pharma Forecasting Software Market Size by Type (2027-2032)
- 10.2.3 Asia Pharma Forecasting Software Market Share by Type (2021-2032)
- 10.3 Asia Pharma Forecasting Software Market Size by Application
- 10.3.1 Asia Pharma Forecasting Software Market Size by Application (2021-2026)
- 10.3.2 Asia Pharma Forecasting Software Market Size by Application (2027-2032)
- 10.3.3 Asia Pharma Forecasting Software Market Share by Application (2021-2032)
- 10.4 Asia Pharma Forecasting Software Market Size by Country
- 10.4.1 Asia Pharma Forecasting Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharma Forecasting Software Market Size by Country (2021-2026)
- 10.4.3 Asia Pharma Forecasting Software Market Size by Country (2027-2032)
- 10.4.4 Asia Pharma Forecasting Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharma Forecasting Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharma Forecasting Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharma Forecasting Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharma Forecasting Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharma Forecasting Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharma Forecasting Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharma Forecasting Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharma Forecasting Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharma Forecasting Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharma Forecasting Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharma Forecasting Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharma Forecasting Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharma Forecasting Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharma Forecasting Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst